Featured Research Search Results
Featured research search results for
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone or Darolutamide (TALENT)
Clinicaltrials.gov identifier:
NCT06844383
Treatment
Phase 2 study for metastatic castration-resistant prostate cancer with an HRR mutation
ERADICATE: Hormone and Targeted Therapy for HR+/HER2-Low Advanced Breast Cancer
Clinicaltrials.gov identifier:
NCT07198724
Treatment
Phase Ib/II study of hormone and targeted therapy for advanced breast cancer
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Clinicaltrials.gov identifier:
NCT06195306
Prevention
Phase 2 prevention study for postmenopausal women ages 45–74 at increased risk for breast cancer
IGNITE-TX - Identifying Individuals for Genetic Testing for Familial Cancer
Clinicaltrials.gov identifier:
NCT07318363
Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested
Research Study on the Genetics of Breast Cancer
Clinicaltrials.gov identifier:
NCT06773897
Surveys, Registries, Interviews
A registry for anyone aged 18 and older who lives in the United States
ShareForCures®: Komen's People-Powered, Data-Driven Breast Cancer Research Registry
Clinicaltrials.gov identifier:
NCT05654246
Surveys, Registries, Interviews
Registry for anyone diagnosed with breast cancer
FIT Testing for Colorectal Cancer Screening in People with Lynch Syndrome
Clinicaltrials.gov identifier:
NCT06898996
Prevention
Colon cancer screening study for people with Lynch syndrome
The ZERO Prostate Cancer BEACON (Barriers, Education, Awareness, Care, Outcomes, and Needs) Survey
Surveys, Registries, Interviews
BEACON is a survey designed to build a comprehensive understanding of the state of prostate cancer awareness and care from the perspectives of men at risk, patient/survivors, caregivers, and healthcare professionals 21 and older.
Virtual Exercise Classes for Adult Cancer Survivors (SURGE)
Clinicaltrials.gov identifier:
NCT07290309
Quality of Life
Exercise study for people diagnosed within the past 5 years
Using a Computer Model to Identify Treatment Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Clinicaltrials.gov identifier:
NCT07067138
Treatment
Treatment study for people with metastatic breast cancer
Previvors’ Perceptions of Preimplantation Genetic Testing (PGT-M) After a Cancer Predisposition Diagnosis
Surveys, Registries, Interviews
Interview for eligible previvors
Treating Advanced MSI-High or dMMR Cancers Using the Targeted Therapy MOMA-341 Given Alone or In Combination with Standard Therapies
Clinicaltrials.gov identifier:
NCT06974110
Treatment
Treatment study for people with advanced or metastatic cancers
Family Communication After Genetic Testing for Colorectal Cancer
Clinicaltrials.gov identifier:
NCT07143487
Prevention
Family communication study after colorectal cancer diagnosis
Understanding Risk Factors for Stomach Cancer in People with Inherited Mutations
Surveys, Registries, Interviews
Online survey on stomach cancer risk for people with an inherited mutation in genes that are linked to an increased risk of cancer
REKINDLE: Your Ability to Cope With a Life-Changing Medical Diagnosis
Clinicaltrials.gov identifier:
NCT07002034
Quality of Life
Study for those experiencing mental health struggles due to a diagnosis of cancer or other medical illness
Testing COM701 Maintenance Treatment to Delay Cancer Growth After Platinum Chemotherapy for Ovarian Cancer That Has Come Back
Clinicaltrials.gov identifier:
NCT06888921
Treatment
Study for relapsed platinum-sensitive ovarian cancer
A New Drug, DT2216, Combined With Paclitaxel for Recurrent Platinum-Resistant Ovarian Cancer
Clinicaltrials.gov identifier:
NCT06964009
Treatment
Phase 1b study for people with recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer
Multi-Cancer Detection Blood Tests in Adults Without Cancer: Vanguard Study
Clinicaltrials.gov identifier:
NCT06995898
Prevention
A study testing two multi-cancer detection blood tests in people who do not have cancer